hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 8.90
+0.05 (0.56%)
At close: Feb 12, 2026
hVIVO Market Cap
hVIVO has a market cap or net worth of 60.21 million as of February 12, 2026. Its market cap has decreased by -53.42% in one year.
Market Cap
60.21M
Enterprise Value
51.63M
Revenue
54.47M
Ranking
n/a
PE Ratio
11.51
Stock Price
8.90
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 60.21M, an increase of 249.31%. That is a compound annual growth rate of 20.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 60.21M | 40.48% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 90.13M |
| 4basebio | 86.67M |
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.78M |
| Ondine Biomedical | 39.98M |
| Poolbeg Pharma | 32.43M |
| ImmuPharma | 31.92M |
| Arecor Therapeutics | 29.26M |